Abstract
Insomnia is a common and growing complaint; 54% of adults report experiencing at least one symptom of insomnia a few nights a week, and 33% of adults report experiencing at least one symptom every night, according to the National Sleep Foundation’s 2005 Sleep in America poll (1) Of those adults experiencing at least one symptom of insomnia a few nights a week, women comprise 57%, whereas men comprise 51% (1), although women are 1.5 times more likely than men to experience insomnia when using full diagnostic criteria (2.)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
National Sleep Foundation. Sleep in America Poll. http://www.sleepfoundation.org/content/hottopics/2005summaryoffindings.pdf, 2005.
Doghramji, P.P., Detection of insomnia in primary care. J Clin Psychiatry, 2001;62(Suppl 10):18–26.
Anonymous, Sleep disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Washington DC: American Psychiatric Publishing. 2000:597–662.
American Academy of Sleep Medicine, The International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual. 2nd ed. Chicago, IL: Author; 2005.
World Health Organization, F50-F59: Behavioural syndromes associated with psychological disturbances and physical factors. The International Statistical Classification of Diseases and Related Health Problems, 10th revision. 1992:174–197.
McClusky, H.Y., J.B. Milby, P.K. Scoitzer, V. Williams, and V. Wooten, Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry, 1991;148(sn1):121–126.
Morin, C.M., C. Colecchi, J. Stone, R. Sood, and D. Brink, Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA, 1999;281(11):991–999.
Smith, M.T., M.L. Perlis, A. Park, et al., Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry, 2002;159(1):5–11.
Spielman, A.J., L.S. Caruso, and P.B. Glovinsky, A behavioral perspective on insomnia treatment. Psychiatr Clin North Am, 1987;10(4):541–553.
Bootzin, R.R. and Nicassio, P.M., Behavioral treatments for insomnia. In: Progress in Behavior Modification (ei]M._Hersen, R. Eissler, P. Miller, eds.). 1978:1–45.
Roehrs, T., E. Hollebeek, C. Drake, and T. Roth, Substance use for insomnia in metropolitan Detroit. J Psychosom Res, 2002;53(1):571–576.
Weiler, J.M., J.R. Bloomfield, G.G. Woodworth, et al., Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med, 2000;132(5):354–363.
Hedner, J., R. Yaeche, G. Emilien, I. Farr, and E. Salinas, Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry, 2000;15(8):704–712.
Israel, A.G. and J.A. Kramer, Safety of zaleplon in the treatment of insomnia. Ann Pharmacother, 2002;36(5):852–859.
Krystal, A.D., J.K. Walsh, E. Laska, et al., Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 2003;26(7):793–799.
Mendelson, W.B., T. Roth, S. Cassella, et al., The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev, 2004;8(1):7–17.
Saletu-Zyhlarz, G., P. Anderer, N. Brandstatter, et al., Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology, 2000;41(3):139–148.
Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(2):249–260.
Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001;44(3):139–149.
Montgomery, I., I. Oswald, K. Morgan, and K. Adam, Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol, 1983;16(2):139–144.
Zhdanova, I.V., R.J. Wortman, M.M. Regan, J.A. Taylor, J.P. Shi, and O.U. Leclair, Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab, 2001;86(10):4727–4730.
Smits, M.G., E.E. Nagtegaal, J. van der Heijden, A.M. Coenen, and G.A. Kerkhof, Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol, 2001;16(2):86–92.
Almeida Montes, L.G., H.P. Ontiveros Uribe, J. Cortes Sotres, and G. Heinze Martin, Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci, 2003;28(3):191–196.
Arendt, J., Complex effects of melatonin. Therapie, 1998;53(5):479–488.
Sack, R.L., A.J. Lewy, and R.J. Hughes, Use of melatonin for sleep and circadian rhythm disorders. Ann Med, 1998;30(1):115–121.
Stone, B.M., C. Turner, S.L. Mills, and A.N. Nicholson, Hypnotic activity of melatonin. Sleep, 2000;23(5):663–669.
Doghramji, P.P., Treatment of insomnia with zaleplon, a novel sleep medication. Int J Clin Pract, 2001;55(5):329–334.
Donath, F., S. Quispe, K. Diefenbach, A. Maurer, I. Fietze, and I. Roots, Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 2000;33(2):47–53.
Dorn, M., (Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study). Forsch Komplementarmed Klass Naturheilkd, 2000;7(2):79–84.
Fussel, A., A. Wolf, and A. Brattstrom, Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res, 2000;5(9):385–390.
Ziegler, G., M. Ploch, A. Miettinen-Baumann, and W. Collett, Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia-a randomized, double-blind, comparative clinical study. Eur J Med Res, 2002;7(11):480–486.
Poyares, D.R., C. Guilleminault, M.M. Ohayon, and S. Tufik, Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(3):539–545.
Zammit, G., T. Roth, M. Erman, S. Sainati, S. Weigand, and J. Zhang, Polysomnography and outpatient study to determine the efficacy of Ramelten in adults with chronic insomnia. 2005;227.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Schuman, C.C. (2006). Nonhormonal Treatments for Insomnia. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-115-4_9
Publisher Name: Humana Press
Print ISBN: 978-1-58829-592-7
Online ISBN: 978-1-59745-115-4
eBook Packages: MedicineMedicine (R0)